Next-generation ‘molecular scissors’ hold promise for patients with chronic hepatitis B

This article emphasizes the potential of a groundbreaking preclinical model that could hold the key to effective treatment for chronic hepatitis B patients. The virus, known for its persistence and resistance to traditional treatments, infects millions globally, especially individuals with weakened immune systems and children. With over 296 million people affected worldwide, particularly in regions like South Africa, finding innovative solutions is crucial. Dr. Smith’s research involves utilizing advanced gene editing techniques to target and halt the progression of the virus.